Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds

Area of Science:

• Cell Biology
• Molecular Oncology
• Drug Discovery

Background:

• Autophagy is a fundamental cellular process involving the degradation and recycling of damaged components to maintain homeostasis.
• Autophagy exhibits a complex, dual role in cancer, acting as both a tumor suppressor and a promoter of tumor growth and drug resistance.
• Cytoprotective autophagy is crucial in many human cancers, making its inhibition a potential therapeutic avenue.

Purpose of the Study:

• To review small-molecule compounds that inhibit autophagy.
• To explore dual-target compounds, combination strategies, and other approaches for enhancing cancer therapy by targeting autophagy.
• To provide insights for developing novel small-molecule inhibitors of cytoprotective autophagy for cancer treatment.

Main Methods:

• Literature review of small-molecule compounds targeting autophagy.
• Analysis of studies on dual-target compounds and combination therapies involving autophagy inhibition.
• Synthesis of information on various strategies to improve cancer therapy through autophagy modulation.

Main Results:

• Identification of various small-molecule compounds with autophagy inhibitory properties.
• Discussion of the potential of dual-target agents and combination strategies in cancer treatment.
• Highlighting the significance of targeting cytoprotective autophagy.

Conclusions:

• Inhibiting cytoprotective autophagy is a viable strategy for cancer therapy.
• Small-molecule compounds targeting autophagy hold promise as anti-cancer drug candidates.
• Further research into novel inhibitors and combination strategies can advance cancer treatment.